Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/6001
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zerdan, Maroun Bou | en_US |
dc.contributor.author | Hassan, Sally Al | en_US |
dc.contributor.author | Shaker, Waleed | en_US |
dc.contributor.author | Hajjar, Rayan El | en_US |
dc.contributor.author | Allam, Sabine | en_US |
dc.contributor.author | Zerdan, Morgan Bou | en_US |
dc.contributor.author | Naji, Amal | en_US |
dc.contributor.author | Zeineddine, Nabil | en_US |
dc.date.accessioned | 2022-08-16T05:51:36Z | - |
dc.date.available | 2022-08-16T05:51:36Z | - |
dc.date.issued | 2022-07 | - |
dc.identifier.issn | 19183003 | - |
dc.identifier.uri | https://scholarhub.balamand.edu.lb/handle/uob/6001 | - |
dc.description.abstract | Carbapenem resistance, an emerging global health problem, compromises the treatment of infections caused by nosocomial pathogens. Preclinical and clinical trials demonstrate that a new generation of carbapenemases inhibitors, together with the recently approved avi-bactam, relebactam and vaborbactam, would address this resistance. Our review summarizes the latest developments related to carbap-enemase inhibitors synthesized to date, as well as their spectrum of activity and their current stage of development. A particular focus will be on β-lactam/β-lactamase inhibitor combinations that could potentially be used to treat infections caused by carbapenemase-producer pathogens. These new combinations mark a critical step forward the fight against antimicrobial resistance. | en_US |
dc.language.iso | eng | en_US |
dc.subject | Carbapenem resistance | en_US |
dc.subject | Carbapenemase inhibitors | en_US |
dc.subject | Pathogens | en_US |
dc.title | Carbapenemase Inhibitors: Updates on Developments in 2021 | en_US |
dc.type | Journal Article | en_US |
dc.identifier.doi | 10.14740/jocmr4764 | - |
dc.identifier.scopus | 2-s2.0-85135510296 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85135510296 | - |
dc.contributor.affiliation | Faculty of Medicine | en_US |
dc.description.volume | 14 | en_US |
dc.description.issue | 7 | en_US |
dc.description.startpage | 251 | en_US |
dc.description.endpage | 259 | en_US |
dc.date.catalogued | 2022-08-16 | - |
dc.description.status | Published | en_US |
dc.identifier.openURL | https://www.jocmr.org/index.php/JOCMR/article/view/4764/25893586 | en_US |
dc.relation.ispartoftext | Journal of Clinical Medicine Research | en_US |
dc.description.campus | SGH campus | en_US |
Appears in Collections: | Faculty of Medicine |
SCOPUSTM
Citations
4
checked on Nov 23, 2024
Record view(s)
39
checked on Nov 23, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.